UB Paderborn / Katalog / Suche / in CDI

The clinical perspective on late-onset depression in European real-world treatment settings

European neuropsychopharmacology, 2024-07, Vol.84, p.59-68

2024

Volltextzugriff (PDF)

Analysis of genetic diversity in patients with major psychiatric disorders versus healthy controls: A molecular-genetic study of 1698 subjects genotyped for 100 candidate genes (549 SNPs)

Psychiatry research, 2024-03, Vol.333, p.115720-115720, Article 115720

2024

Volltextzugriff (PDF)

Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical Trial

Schizophrenia bulletin, 2023-07, Vol.49 (4), p.893-902

2023

Volltextzugriff (PDF)

Comparison of etomidate and methohexital as anesthetic agents for continuation and maintenance electroconvulsive therapy: A retrospective analysis of seizure quality and safety

Journal of affective disorders, 2023-06, Vol.330, p.33-39

2023

Volltextzugriff (PDF)

Silexan for treatment of psychiatric manifestations in the context of COVID-19: a case series

European psychiatry, 2023-03, Vol.66 (S1), p.S798-S799

2023

Volltextzugriff (PDF)

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part II: OCD and PTSD

The world journal of biological psychiatry, 2023-02, Vol.24 (2), p.118-134

2023

Volltextzugriff (PDF)

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders

The world journal of biological psychiatry, 2023-02, Vol.24 (2), p.79-117

2023

Volltextzugriff (PDF)

Randomized controlled clinical trial of the efficacy of the digital self- help program edupression.com® in mild-to-moderate unipolar depressive patients (eFICASY-study)

Neuroscience Applied, 2023, Vol.2, p.103615, Article 103615

2023

Volltextzugriff (PDF)

Effects of social isolation on neurotransmitter levels in the pallidum in recurrent major depressive disorder

Neuroscience Applied, 2023, Vol.2, p.102896, Article 102896

2023

Volltextzugriff (PDF)

Association between polygenic risk scores of subcortical brain volumes and antidepressant response: a meta-analysis

Neuroscience Applied, 2023, Vol.2, p.102912, Article 102912

2023

Volltextzugriff (PDF)

Rare missense variant (R251G) on APOE counterbalances the Alzheimer’s disease risk associated with APOE‐ε4

Alzheimer's & dementia, 2022-12, Vol.18 (S4), p.n/a

2022

Volltextzugriff (PDF)

Protective association of HLA‐DRB1 04 subtypes in neurodegenerative diseases implicates acetylated tau PHF6 sequences

Alzheimer's & dementia, 2022-12, Vol.18 (S3)

2022

Volltextzugriff (PDF)

Polygenic risk scores for neuropsychiatric, inflammatory, and cardio‐metabolic traits highlight possible genetic overlap with suicide attempt and treatment‐emergent suicidal ideation

American journal of medical genetics. Part B, Neuropsychiatric genetics, 2022-04, Vol.189 (3-4), p.74-85

2022

Volltextzugriff (PDF)

Pharmacogenetics of CYP2C19 in response and side effects to major depression treatment: a machine learning approach

Neuroscience Applied, 2022, Vol.1, p.100482, Article 100482

2022

Volltextzugriff (PDF)

Genetic dissection of the clinical heterogeneity of major depressive disorder

Neuroscience Applied, 2022, Vol.1, p.100480, Article 100480

2022

Volltextzugriff (PDF)

P.0882 A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response

European neuropsychopharmacology, 2021-12, Vol.53, p.S646-S647

2021

Volltextzugriff (PDF)

Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years

Molecular psychiatry, 2021-10, Vol.26 (10), p.5812-5822

2021

Volltextzugriff (PDF)

Correction: Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years

Molecular psychiatry, 2021-10, Vol.26 (10), p.5823-5823

2021

Volltextzugriff (PDF)

HLA-DQB1 6672G>C (rs113332494) is associated with clozapine-induced neutropenia and agranulocytosis in individuals of European ancestry

Translational psychiatry, 2021-04, Vol.11 (1), p.214-214, Article 214

2021

Volltextzugriff (PDF)

Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity-impulsivity symptoms in ADHD measured with PET

Molecular psychiatry, 2021-03, Vol.26 (3), p.1009-1018

2021

Volltextzugriff (PDF)

Shared genetic risk between eating disorder‐ and substance‐use‐related phenotypes: Evidence from genome‐wide association studies

Addiction biology, 2021-01, Vol.26 (1), p.e12880-n/a

2021

Volltextzugriff (PDF)

P.335 Drug repositioning for treatment-resistant depression by comparing genetic predictors with known drug targets

European neuropsychopharmacology, 2020-11, Vol.40, p.S195-S196

2020

Volltextzugriff (PDF)

P.141 Topological data analysis for genetic-driven stratification of patients with major depressive disorder

European neuropsychopharmacology, 2020-11, Vol.40, p.S86-S87

2020

Volltextzugriff (PDF)

P.179 Polygenic risk scores for multiple psychiatric, inflammatory and cardio-metabolic traits highlight possible genetic overlap with suicide attempt

European neuropsychopharmacology, 2020-11, Vol.40, p.S105-S106

2020

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

The clinical perspective on late-onset depression in European real-world treatment settings

Analysis of genetic diversity in patients with major psychiatric disorders versus healthy controls: A molecular-genetic study of 1698 subjects genotyped for 100 candidate genes (549 SNPs)

Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical Trial

Comparison of etomidate and methohexital as anesthetic agents for continuation and maintenance electroconvulsive therapy: A retrospective analysis of seizure quality and safety

Silexan for treatment of psychiatric manifestations in the context of COVID-19: a case series

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part II: OCD and PTSD

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders

Randomized controlled clinical trial of the efficacy of the digital self- help program edupression.com® in mild-to-moderate unipolar depressive patients (eFICASY-study)

Effects of social isolation on neurotransmitter levels in the pallidum in recurrent major depressive disorder

Association between polygenic risk scores of subcortical brain volumes and antidepressant response: a meta-analysis

Rare missense variant (R251G) on APOE counterbalances the Alzheimer’s disease risk associated with APOE‐ε4

Protective association of HLA‐DRB1 04 subtypes in neurodegenerative diseases implicates acetylated tau PHF6 sequences

Polygenic risk scores for neuropsychiatric, inflammatory, and cardio‐metabolic traits highlight possible genetic overlap with suicide attempt and treatment‐emergent suicidal ideation

Pharmacogenetics of CYP2C19 in response and side effects to major depression treatment: a machine learning approach

Genetic dissection of the clinical heterogeneity of major depressive disorder

P.0882 A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response

A genome-wide meta-analysis uncovers six sequence variants conferring risk of vertigo

Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years

Correction: Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years

HLA-DQB1 6672G>C (rs113332494) is associated with clozapine-induced neutropenia and agranulocytosis in individuals of European ancestry

Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity-impulsivity symptoms in ADHD measured with PET

Shared genetic risk between eating disorder‐ and substance‐use‐related phenotypes: Evidence from genome‐wide association studies

P.335 Drug repositioning for treatment-resistant depression by comparing genetic predictors with known drug targets

P.141 Topological data analysis for genetic-driven stratification of patients with major depressive disorder

P.179 Polygenic risk scores for multiple psychiatric, inflammatory and cardio-metabolic traits highlight possible genetic overlap with suicide attempt

Suchergebnisse filtern